Trial NCT00468910

Aspirin in Preventing Colorectal Cancer in Patients at Increased Risk of Colorectal Cancer

This randomized phase II trial is studying how well aspirin works in preventing colorectal
cancer in patients at increased risk of colorectal cancer. Chemoprevention is the use of
certain drugs to keep cancer from forming. The use of aspirin may prevent colorectal cancer.


acetylsalicylic acid, placebo, laboratory biomarker analysis


Colon Cancer, Precancerous Condition, Rectal Cancer


See list of participating sites